On March 24, 2020, the State of Ohio Board of Pharmacy (“OBP”) took additional COVID-19 response efforts to protect the health and safety of Ohioans during the COVID-19 outbreak. These efforts include, but are not limited to:
- Authorized expedited licensure of drug distributors; and
- Authorized sale and shipment of non-reportable dangerous drugs that are in shortage by unlicensed, out-of-state facilities.
The OBP also reminded its licensees that pharmacies and terminal distributors of dangerous drugs are not required to submit a notification to the OBP for any temporary closures or reduction in operating hours. If modifying operating hours, a pharmacy must update signage to reflect the change in store hours.
As a reminder, the OBP also implemented required infection control procedures effective March 19, 2020.
Read more HERE.
If you are seeking guidance concerning obtaining expedited licensure as a drug distributor or have questions concerning OBP requirements during COVID-19, contact Todd Collis.
Ohio Medical Board Defense Counsel Blog 